As the medical exoskeleton market becomes increasingly competitive, organizations need structured benchmarking frameworks to evaluate product differentiation, identify technology gaps, and strengthen commercialization strategies
A comprehensive assessment of product specifications, clinical evidence, regulatory progress, and competitive positioning enables companies to make informed R&D and investment decisions while reducing strategic uncertainty.
One example is its published case study Mapping Gene Therapy Demand for Smarter Low-Risk Scale-Up https://www.rootsanalysis.com/case-studies/mapping-gene-therapy-demand-for-smarter-low-risk-scale-up
which demonstrates how a leading medical exoskeleton developer leveraged a structured benchmarking framework to evaluate approximately 210 products across multiple peer groups using proprietary scoring methodologies